Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,215.35
-8.3 (-0.68%)
BSENSE

Dec 05

BSE+NSE Vol: 4.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
58.08
58.59
58.59
58.59
58.59
58.59
Share Warrants & Outstandings
Total Reserve
32,595.24
29,784.21
26,781.26
24,517.39
21,871.28
16,766.08
Shareholder's Funds
32,653.32
29,842.80
26,839.85
24,575.98
21,929.87
16,824.67
Minority Interest
-6.39
8.00
12.00
-1.93
-0.88
0.13
Long-Term Borrowings
1,561.65
2,134.90
618.96
249.21
168.49
0.00
Secured Loans
1,159.38
2,134.90
618.96
249.21
168.49
0.00
Unsecured Loans
402.27
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-989.69
-856.08
-287.88
122.37
121.88
128.49
Other Long Term Liabilities
307.85
304.42
363.07
359.73
359.79
351.89
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
282.93
225.70
172.72
171.79
157.11
74.71
Total Non-Current Liabilities
1,162.74
1,808.94
866.87
903.10
807.27
555.09
Current Liabilities
Trade Payables
4,188.85
4,454.16
3,871.31
2,703.05
2,794.68
2,576.06
Other Current Liabilities
3,837.90
3,307.86
3,179.38
3,158.81
2,894.66
2,969.64
Short Term Borrowings
6,380.03
4,180.32
4,242.56
2,123.56
4,803.78
5,422.30
Short Term Provisions
275.56
256.79
200.53
170.56
171.93
416.64
Total Current Liabilities
14,682.34
12,199.13
11,493.78
8,155.98
10,665.05
11,384.64
Total Liabilities
48,492.01
43,858.87
39,212.50
33,633.13
33,401.31
28,764.54
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
23,954.19
22,999.96
17,956.10
14,825.29
13,038.94
0.00
Less: Accumulated Depreciation
9,454.41
8,791.85
7,384.42
4,801.21
4,078.81
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
14,499.78
14,208.11
10,571.68
10,024.08
8,960.13
9,396.47
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
3,266.00
2,739.39
4,496.40
2,937.56
2,428.89
1,621.80
Intangible assets under development
1,633.96
1,129.33
893.61
809.64
632.64
364.12
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
251.70
321.65
391.74
618.30
431.22
554.69
Long Term Loans & Advances
865.10
714.55
794.00
575.33
658.44
378.34
Other Non Current Assets
518.60
689.24
153.15
37.52
53.03
36.61
Total Non-Current Assets
21,329.55
20,086.95
17,752.59
15,510.44
13,577.80
12,352.03
Current Assets Loans & Advances
Current Investments
0.01
50.58
151.00
378.85
159.79
0.02
Inventories
10,543.72
9,808.23
8,511.23
7,553.85
9,026.57
7,699.87
Sundry Debtors
5,745.93
4,816.74
4,466.38
4,012.26
3,503.28
4,315.16
Cash and Bank
8,235.49
6,278.30
6,084.20
4,190.01
5,474.28
2,842.15
Other Current Assets
540.70
324.35
458.23
743.04
680.27
505.11
Short Term Loans and Advances
2,096.61
2,493.72
1,788.87
1,244.68
979.32
1,050.20
Total Current Assets
27,162.46
23,771.92
21,459.91
18,122.69
19,823.51
16,412.51
Net Current Assets (Including Current Investments)
12,480.12
11,572.79
9,966.13
9,966.71
9,158.46
5,027.87
Total Current Assets Excluding Current Investments
27,162.45
23,721.34
21,308.91
17,743.84
19,663.72
16,412.49
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
48,492.01
43,858.87
39,212.50
33,633.13
33,401.31
28,764.54
Contingent Liabilities
368.26
311.34
158.53
157.74
140.83
145.98
Total Debt
7,941.68
6,315.22
4,861.52
2,372.77
4,972.27
5,561.97
Book Value per share (adjusted)
562.21
509.35
458.1
419.46
374.29
287.16
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 25.75% vs 29.90% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 1.13% vs -16.15% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 4.83% vs 12.47% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is -21.75% vs -17.89% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 14.26% vs 10.77% in Mar 2024

Compare Balance Sheet Results of Aurobindo Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
58.08
41.26
16.82
40.77%
Share Warrants & Outstandings
Total Reserve
32,595.24
14,247.46
18,347.78
128.78%
Shareholder's Funds
32,653.32
14,332.39
18,320.93
127.83%
Minority Interest
-6.39
235.79
-242.18
-102.71%
Long-Term Borrowings
1,561.65
5,526.19
-3,964.54
-71.74%
Secured Loans
1,159.38
5,088.86
-3,929.48
-77.22%
Unsecured Loans
402.27
437.33
-35.06
-8.02%
Deferred Tax Assets / Liabilities
-989.69
1,704.62
-2,694.31
-158.06%
Other Long Term Liabilities
307.85
34.03
273.82
804.64%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
282.93
155.06
127.87
82.46%
Total Non-Current Liabilities
1,162.74
7,419.90
-6,257.16
-84.33%
Current Liabilities
Trade Payables
4,188.85
1,133.40
3,055.45
269.58%
Other Current Liabilities
3,837.90
909.45
2,928.45
322.00%
Short Term Borrowings
6,380.03
2,956.84
3,423.19
115.77%
Short Term Provisions
275.56
663.87
-388.31
-58.49%
Total Current Liabilities
14,682.34
5,663.56
9,018.78
159.24%
Total Liabilities
48,492.01
27,651.64
20,840.37
75.37%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
23,954.19
20,723.51
3,230.68
15.59%
Less: Accumulated Depreciation
9,454.41
1,886.28
7,568.13
401.22%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
14,499.78
18,837.23
-4,337.45
-23.03%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
3,266.00
306.13
2,959.87
966.87%
Intangible assets under development
1,633.96
519.54
1,114.42
214.50%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
251.70
351.14
-99.44
-28.32%
Long Term Loans & Advances
865.10
293.08
572.02
195.18%
Other Non Current Assets
518.60
189.00
329.60
174.39%
Total Non-Current Assets
21,329.55
20,663.37
666.18
3.22%
Current Assets Loans & Advances
Current Investments
0.01
1,690.84
-1,690.83
-100.00%
Inventories
10,543.72
2,093.71
8,450.01
403.59%
Sundry Debtors
5,745.93
1,538.34
4,207.59
273.51%
Cash and Bank
8,235.49
554.50
7,680.99
1,385.21%
Other Current Assets
540.70
100.12
440.58
440.05%
Short Term Loans and Advances
2,096.61
1,010.76
1,085.85
107.43%
Total Current Assets
27,162.46
6,988.27
20,174.19
288.69%
Net Current Assets (Including Current Investments)
12,480.12
1,324.71
11,155.41
842.10%
Total Current Assets Excluding Current Investments
27,162.45
5,297.43
21,865.02
412.75%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48,492.01
27,651.64
20,840.37
75.37%
Contingent Liabilities
368.26
1,046.73
-678.47
-64.82%
Total Debt
7,941.68
8,483.03
-541.35
-6.38%
Book Value per share (adjusted)
562.21
347.37
214.84
61.85%
Annual - Borrowings
Borrowings 7,941.68 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.75% vs 29.90% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 307.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.13% vs -16.15% in Mar 2024

Annual - Fixed Assets
Fixed Assets 17,765.78 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.83% vs 12.47% in Mar 2024

Annual - Investments
Investments 251.70 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.75% vs -17.89% in Mar 2024

Annual - Current Assets
Current Assets 27,162.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.26% vs 10.77% in Mar 2024